相关实验视频
Updated: Jul 17, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.2K
铁酸纳米颗粒通过纳米催化剂抗氧化和氧化来缓解类风湿性关节炎
Bowen Yang1, Jianlin Shi1,2
1Shanghai Institute of Ceramics, Chinese Academy of Sciences, Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012), Shanghai 200050, P. R. China.
Nano letters
|September 1, 2023
概括
这项研究引入了化纳米颗粒来治疗类风湿性关节炎 (RA),通过将有害的活性氧物种 (ROS) 转化为氧气. 这种双重作用减轻了RA的炎症和缺氧.
科学领域:
- 生物化学 生物化学
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 类风湿性关节炎 (RA) 涉及氧化应激和缺氧.
- 反应性氧物种 (ROS) 和氧气 (O2) 是RA发病的关键与氧气相关的因素.
研究的目的:
- 通过同时减轻氧化应激和缺氧,开发RA的催化疗法.
- 为了研究铁酸纳米颗粒在治疗RA中的有效性.
主要方法:
- 铁酸纳米颗粒的合成,具有类似催化酶的活性.
- 用铁化物将过氧化 (H2O2) 催化转化为O2.
- 在体外细胞和体内动物实验中评估RA治疗疗效.
主要成果:
- 铁酸纳米粒子有效地分解了H2O2,产生了O2.
- 该纳米材料显示出显著的抗氧化和氧化能力.
- 细胞和体内研究都证实了铁酸纳米颗粒对RA的治疗潜力.
结论:
- 铁酸纳米颗粒通过解决氧化应激和缺氧,为治疗RA提供了一种协同方法.
- 这种催化疗法为具有氧化还原失衡和缺氧特征的炎症性疾病提供了一种新的方法.
相关概念视频
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.3K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.3K
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K

